The National Science Foundation (NSF) awarded a $1,000,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to Oakgrove Bio LLC, a for-profit organization located in Talleyville, DE. The goal of this SBIR Phase II project is to accelerate the commercialization of bioactive and structural peptides by developing a cost-effective recombinant peptide production platform. The project aims to scale up a novel microbial cell factory technology that can dramatically reduce the manufacturing costs of peptides, which currently hinders their broader adoption despite their significant potential applications in areas like antimicrobials, tissue engineering, and chronic disease treatment. The award period runs from March 2025 to February 2027.
Generated 4/1/25, 4:15 AM